Search
We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.
Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.
Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.
MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.
Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.
The June 29 edition of “MSK Science Spotlight” will feature chemical biologist Yael David, PhD, “Uncovering Epigenetic Events that Drive Oncogenesis.